The Effect of Eyelid Surgery on Dry Eye - a Prospective Study
|ClinicalTrials.gov Identifier: NCT02376556|
Recruitment Status : Completed
First Posted : March 3, 2015
Last Update Posted : October 15, 2019
|Condition or disease|
|Dry Eye Syndrome Ptosis Dermatochalasis|
Patients who are referred for blepharoplasty with or without muller muscle resection in the oculoplastic clinic in the investigators institution, will be offered to participate in the study. After filling and informed consent form, patients recruited will fill in a questionnaire about dry eye symptoms, and will be examined by an ophthalmologist for visual acuity, intra ocular pressure, anterior segment examination using a slit lamp biomicroscopy, schirmer test, tear break up time assessment and tear osmolarity. These are all standard examination in ophthalmology. The surgical procedure planned to correct the eyelid pathology will not be affected by the results of these examinations.
The same combination of ophthalmic examination will by done on postoperative follow-up examination 1 week, 1 month and 3 months after the surgery. Dry eye questionnaire will be filled in by the patients on postoperative follow-up examination 1 month and 3 months after the surgery.
This data will help us assess the effect of these common surgical procedures on dry eye symptoms.
|Study Type :||Observational|
|Actual Enrollment :||54 participants|
|Official Title:||The Prevalence of Dry Eye Syndrome Among Patients Who Underwent Upper Eyelids Blepharoplasty With and Without Muller Muscle Resection|
|Actual Study Start Date :||March 2015|
|Actual Primary Completion Date :||March 2018|
|Actual Study Completion Date :||March 2018|
patients undergoing upper eyelid blepharoplasty
blepharoplasty and muller muscle resection
patients undergoing a combined blepharoplasty and muller muscle resection surgery
- Objective assessment of dry eye syndrome [ Time Frame: 3 months postoperatively ]
- Subjective assessment of dry eye syndrome [ Time Frame: 3 months postoperatively ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02376556
|Ramat Gan, Israel, 52621|
|Principal Investigator:||Guy J Ben Simon, MD||Sheba Medical Center, Israel|